Vascular smooth muscle actin cytoskeleton in cerebral artery forced dilatation

Stroke

Volumn 29, Issue 6, 1998, Pages 1223-1228

  Cipolla, Marilyn J ^a   Osol, George ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

Actin cytoskeleton; Cerebral arteries; Forced dilatation; Rats

Indexed keywords

ACTIN; CYTOCHALASIN B;

ACTIN POLYMERIZATION; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; BRAIN ARTERY; BRAIN CIRCULATION; CONTROLLED STUDY; CYTOSKELETON; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0031781521     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.6.1223     Document Type: Article

References (33)

1. Harper SL, Bohlen HG, Rubin MH. Arterial and microvascular contributions to cerebral cortical autoregulation in rats. Am J Physiol. 1984; 246:HI7-H24.
2. Mueller SM, Heistad DD, Marcus ML. Total and regional cerebral blood flow during hypotension, hypertension and hypocapnia. Circ Res. 1977; 41:350-356.
3. Johansson B. Myogenic tone and reactivity: definitions based on muscle physiology. J Hypertens. 1989;7(suppl 4):S5-S8.
4. Mellander S. Functional aspects of myogenic vascular control. J Hypertens. 1989;7(suppl 4):S21-S30.
5. Osol G. Mechanotransduction by vascular smooth muscle. J Vasc Res. 1995;32:275-292.
6. Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993;260:1124-1127.
7. Sims J, Karp S, Ingber DE. Altering the cellular mechanical force balance results in integrated changes in cell, cytoskeletal and nuclear shape. J Cell Sci. 1992;103:1215-1222.
8. Bearer EL. Role of actin polymerization in cell locomotion: molecules and models. Am J Respir Cell Mol Biol. 1993;8:582-591.
9. Wang Y-L. Mobility of filamentous actin in living cytoplasm. J Cell Biol. 1987;105:2811-2816.
10. Banes AJ, Tsuzaki M, Yamamoto J, Fischer T, Brigman B, Brown T, Miller L. Mechanoreception at the cellular level: the detection, interpretation and diversity of responses to mechanical signals. Biochem Cell Biol. 1995;73:349-365.
11. Fawcett DW. A Textbook of Histology. 11th ed. Philadelphia, Pa: WB Saunders; 1986.
12. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL Jr. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol. 1978;234:H371-H383.
13. Skinhøj E, Strandgaard S. Pathogenesis of hypertensive encephalopathy. Lancet. 1973;1:461-462.
14. Strandgaard S, MacKenzie ET, Sengupta D, Rowan JP, Lassen NA, Harper AM. Upper limit of autoregulation of cerebral blood flow in the baboon. Circ Res. 1974;34:435-440.
15. Johansson B, Strandgaard S, Lassen NA. On the pathogenesis of hypertensive encephalopathy (the hypertensive 'breakthrough' of autoregulation of cerebral blood flow with forced dilatation, flow increase, and acute blood-brain barrier damage). Circ Res. 1974;34-35(suppl I):I-167-I-174.
16. Baumbach GL, Heistad DD. Heterogeneity of brain blood flow and permeability during acute hypertension. Am J Physiol. 1985;249: H629-H637.
17. MacKenzie ET, Strandgaard S, Graham DI, Jones JV, Harper AM, Farrar JK. Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow and the blood-brain barrier. Circ Res. 1976;39:33-41.
18. Tamaki KT, Sadoshima S, Baumbach GL, Iadecola C, Reis DJ, Heistad DD. Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy. Hypertension. 1984;6(suppl I):I-75-I-81.
19. Johansson BB. The effects of an acute increase in the intravascular pressure on the blood-brain barrier (a comparison between conscious and anesthetized rats). Stroke. 1978;9:588-590.
20. Byrom FB. The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension. Lancet. 1954;2:201-211.
21. Kontos HA, Wei EP, Dietrich WE, Navari RM, Povlishock JT, Ghatak NR, Ellis EF, Patterson JL Jr. Mechanism of cerebral arteriolar abnormalities after acute hypertension. Am J Physiol. 1981;240:H511-H527.
22. Mayhan WG, Heistad DD. Permeability of blood brain barrier to various sized molecules. Am J Physiol. 1985;248:H712-H718.
23. Byrom F. Spasm, constriction, and hypertensive cerebral arteries. Am Heart Journal. 1975;90:676-677.
24. Byrom FB. The Hypertensive Vascular Crisis, an Experimental Study. London. England: William Heinemann, Ltd; 1969.
25. Cooper JA. Effects of cytochalasin and phalloidin on actin. J Cell Biol. 1987;105:1473-1478.
26. Urbanik E, Ware BR. Actin filament capping and cleaving activity of cytochalasins B, D, E, and H. Arch Biochem Biophys. 1989;269:181-187.
27. Osol G, Halpern W. Myogenic properties of cerebral arteries from normotensive and hypertensive rats. Am J Physiol. 1985;249:H914-H921.
28. Halpern W, Osol G, Coy G. Mechanical behavior of pressurized in vitro prearteriolar vessels as determined with a video system. Ann Biomed Eng. 1984;12:463-479.
29. Osol G, Laher I, and Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res. 1991;68:359-367.
30. Bubb MR, Senderowicz AMJ, Sausville EA, Duncan KLK, Korn ED. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem. 1994;269:14869-14871.
31. Cipolla MJ, Osol G. Actin polymerization is induced by pressure in vascular smooth muscle cells and causes contraction of cerebral arteries. Circulation. 1997;96:1-50. Abstract.
32. Mauss S, Koch G, Kreue VAW, Akorties K. Inhibition of the contraction of the isolated longitudinal muscle of the guinea pig ileum by botulinum C2 toxin: evidence for a role of G/F-actin transition in smooth muscle contraction. Naunyn Schmiedebergs Arch Pharmacol. 1989;340: 345-351.
33. Obara K, Yabu H. Effect of cytochalasin B on intestinal smooth muscle cells. Eur J Pharmacol. 1994;255:139-147.